Phaxiam Therapeutics Sa (NASDAQ: PHXM) is owned by 4.38% institutional shareholders, 0.00% Phaxiam Therapeutics Sa insiders, and 95.62% retail investors. Vanguard Personalized Indexing Management LLC is the largest individual Phaxiam Therapeutics Sa shareholder, owning 24,271.00 shares representing 0.78% of the company. Vanguard Personalized Indexing Management LLC's Phaxiam Therapeutics Sa shares are currently valued at $120.00k.
If you're new to stock investing, here's how to buy Phaxiam Therapeutics Sa stock.